Intermittent Fasting and Mediterranean Diet in Patient With Multiple S
Determination of the Effects of Intermittent Fasting and Mediterranean Diet on Quality of Life, Circadian Rhythm and Appetite Markers in Patient With Multiple Sclerosis
What it found
No result yet.
What was tested
Treatment tested
- application of different types of diet
What it measured
Main measures
Biochemical parameter
baseline- 3 months
Other measures (3)
The Morning and Evening Questionnaire
baseline- 3 months
Pittsburgh Sleep Quality Index
baseline- 3 months
Mood and sleepMultiple Sclerosis Quality of Life-MuSiQoL
baseline- 3 months
Bladder, bowel and sexual functionQuality of life (reported by participants)
Who could take part
MS (type not specified) · 18 to 65
Show the full criteria
Inclusion criteria
* To apply to the neurology outpatient clinic, to be a female between the ages of 18-65 who has been diagnosed with MS by a physician * Not being in the attack period * Not being in menopause Not being diagnosed with any autoimmune system disease other than -MS that may adversely affect the study, * Not following the Mediterranean diet and intermittent fasting programmes in the last three months, * Not being diagnosed with an eating behaviour disorder, * Not having any communication problems, * Signing the informed consent form, * Brain MRI within the last three months, * Not to be pregnant and lactating * No physical disability No history of cancer * Body Mass Index between 18,5 kg/m2- 29,9 kg/m2, * Not losing 5% and/or more body weight in the last month
Exclusion criteria
* Having a diagnosis of autoimmune system disease that may adversely affect working outside of -MS, * To be in the attack period-Being under 18 years of age and over 65 years of age * Being in menopause-Mediterranean diet and intermittent fasting feeding programmes within the last three months, * Diet therapy that has an effect on the autoimmune system within the last three months, * Being diagnosed with eating behaviour disorder, * Having any communication problems,- Not signing the informed consent form, * Failure to adapt to the work during the working period, to be in a situation/behaviour that may adversely affect the work, * To have applied any nutritional intervention during the last three months prior to the study, * Taking supplements such as selenium, zinc, iron, vitamin D and/or B12, which may affect the course of the study, * To have received cancer treatment and / or to be receiving cancer treatment, * Other neurological diseases (e.g. Parkinson's, epilepsy, Alzheimer's), * Diagnosed with a disease lasting more than 4 months in the last 12 months and other specialised dietary / compositionally different dietary patterns (e.g. high protein, ketogenic, low energy content \< 1000 kcal/day), * Body Mass Index \<18.5 kg/m2 or >30 kg/m2 * Losing 5% and/or more body weight in the last month, * Having a physical disability
As registered. Criteria can change, so ask the trial team or your neurologist.
Contact details on the registryAbout this trial
In the sponsor's words
When the literature was reviewed, there is no study in which the effects of intermittent fasting and Mediterranean diet on quality of life, sleep, circadian rhythm and appetite hormones leptin and ghrelin levels in MS patients were evaluated and the two diet types were comparatively examined in terms of all these parameters.
Papers
Loading reviews and guidelines…
History
Started
May 2024
Main results due
Sept 2026
Finished
Dec 2026